118 related articles for article (PubMed ID: 19384918)
1. Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.
Duffy A; Capanu M; Allen P; Kurtz R; Olson SH; Ludwig E; Klimstra DS; O'Reilly EM
J Surg Oncol; 2009 Jul; 100(1):8-12. PubMed ID: 19384918
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic adenocarcinoma in young adults in a moroccan population.
Raissouni S; Rais G; Mrabti H; Raissouni F; Mouzount H; Aitelhaj M; El Khoyaali S; Mohtaram A; Errihani H
J Gastrointest Cancer; 2012 Dec; 43(4):607-11. PubMed ID: 22760710
[TBL] [Abstract][Full Text] [Related]
3. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).
Duffy A; Capanu M; Abou-Alfa GK; Huitzil D; Jarnagin W; Fong Y; D'Angelica M; Dematteo RP; Blumgart LH; O'Reilly EM
J Surg Oncol; 2008 Dec; 98(7):485-9. PubMed ID: 18802958
[TBL] [Abstract][Full Text] [Related]
4. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?
Kim HJ; Czischke K; Brennan MF; Conlon KC
J Gastrointest Surg; 2002; 6(5):763-9. PubMed ID: 12399067
[TBL] [Abstract][Full Text] [Related]
5. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.
Huang L; Jansen L; Balavarca Y; Babaei M; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Primic-Žakelj M; Zadnik V; Besselink MG; Schrotz-King P; Brenner H
BMC Med; 2018 Aug; 16(1):125. PubMed ID: 30126408
[TBL] [Abstract][Full Text] [Related]
6. Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer.
Golan T; Sella T; O'Reilly EM; Katz MH; Epelbaum R; Kelsen DP; Borgida A; Maynard H; Kindler H; Friedmen E; Javle M; Gallinger S
Br J Cancer; 2017 Mar; 116(6):697-702. PubMed ID: 28183138
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior.
Sahin IH; Elias H; Chou JF; Capanu M; O'Reilly EM
BMC Cancer; 2018 Jul; 18(1):769. PubMed ID: 30055578
[TBL] [Abstract][Full Text] [Related]
8. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
[TBL] [Abstract][Full Text] [Related]
9. The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.
Ferrone CR; Haas B; Tang L; Coit DG; Fong Y; Brennan MF; Allen PJ
J Gastrointest Surg; 2006 Dec; 10(10):1347-53. PubMed ID: 17175453
[TBL] [Abstract][Full Text] [Related]
10. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion.
Park SJ; Jang S; Han JK; Kim H; Kwon W; Jang JY; Lee KB; Kim H; Lee DH
Eur Radiol; 2021 Sep; 31(9):6889-6897. PubMed ID: 33740095
[TBL] [Abstract][Full Text] [Related]
11. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.
Wasif N; Bentrem DJ; Farrell JJ; Ko CY; Hines OJ; Reber HA; Tomlinson JS
Cancer; 2010 Jul; 116(14):3369-77. PubMed ID: 20564064
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
Mayo SC; Austin DF; Sheppard BC; Mori M; Shipley DK; Billingsley KG
Cancer; 2010 Jun; 116(12):2932-40. PubMed ID: 20336787
[TBL] [Abstract][Full Text] [Related]
13. Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort.
Pietrasz D; Marthey L; Wagner M; Blanc JF; Laurent C; Turrini O; Raoul JL; Terrebonne E; Hentic O; Trouilloud I; Coriat R; Regenet N; Innominato P; Taieb J; Cunha AS; Bachet JB
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1196-205. PubMed ID: 26271395
[TBL] [Abstract][Full Text] [Related]
14. Identification of distinct phenotypes of locally advanced pancreatic adenocarcinoma.
Teo M; Crotty GF; O'Súilleabháin C; Ridgway PF; Conlon KC; Power DG; McDermott RS
J Gastrointest Cancer; 2013 Mar; 44(1):73-8. PubMed ID: 22829058
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.
Picozzi VJ; Oh SY; Edwards A; Mandelson MT; Dorer R; Rocha FG; Alseidi A; Biehl T; Traverso LW; Helton WS; Kozarek RA
Ann Surg Oncol; 2017 Jun; 24(6):1722-1730. PubMed ID: 28054192
[TBL] [Abstract][Full Text] [Related]
17. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
18. Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.
Hicks AM; Chou J; Capanu M; Lowery MA; Yu KH; O'Reilly EM
Clin Colorectal Cancer; 2016 Dec; 15(4):360-368. PubMed ID: 27262896
[TBL] [Abstract][Full Text] [Related]
19. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
